Recently, TWEAK has been a focus of attention in the research community as a potential regulator of the low-grade chronic inflammation characteristic of obesity (extensively reviewed in Burkly [105]). Here, TNFSF12 is linked to obesity due to melanocortin 4 receptor deficiency.